Treatments for Insomnia in Veterans With PTSD
Part of paid clinical trials in Sepulveda, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05194930
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- The ABC of Insomnia (Acceptance and the Behavioral Changes to treat Insomnia) — BEHAVIORAL5 individual sessions incorporating behavioral treatment components plus acceptance and commitment therapy (ACT) provided by a trained instructor.
- Cognitive-Behavioral Therapy for Insomnia — BEHAVIORAL5 individual sessions incorporating behavioral and cognitive therapy components with a trained instructor.
Study Details
This randomized trial will compare a novel treatment, Acceptance of the Behavioral Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I combines the behavioral components of CBT-I with components of another behavioral therapy (Acceptance and Commitment Therapy) and has been shown to improve treatment adherence. The study objectives are: 1) to evaluate the benefits of ABC-I in reducing post-traumatic stress disorder (PTSD) symptoms among Veterans with comorbid PTSD and insomnia disorder compared to CBT-I, and 2) to evaluate the effectiveness of ABC-I in improving insomnia symptoms and sleep quality among Veterans with comorbid PTSD and insomnia disorder as compared to CBT-I. Veterans with insomnia and comorbid PTSD who receive care at Sepulveda and West Los Angeles facilities will be recruited for the study. Those who pass an initial eligibility screen will be enrolled and written informed consent will be obtained. A baseline assessment will be completed that includes measures of sleep, PTSD, and quality of life. Veterans who meet all eligibility criteria will be randomly assigned to the ABC-I (n=100) or CBT-I (n=100) treatment. Both treatments will be provided in 5 one-on-one sessions by a trained instructor who is supervised by a behavioral sleep medicine specialist. All randomized participants (n=200) will have 3 follow-up assessments (post-treatment, 3-months, and 6-months after randomization). The follow-up assessments will collect information on PTSD symptoms, insomnia symptoms and sleep quality.
Key Dates
- Start date
- Sep 1, 2022
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: The ABC of Insomnia (Acceptance and the Behavioral Changes toThis is the new treatment arm that is being compared to CBT-I, standard treatment for insomnia.
- Active Comparator: Cognitive-Behavioral Therapy for InsomniaThis is the standard treatment for insomnia that is being compared to the new treatment (ABCI).
Primary Outcome Measure
PTSD Check List for DSM-5 (PCL-5) [ Time Frame: 6-months follow-up ]
Central Contacts
- Jennifer L Martin, PhD(818) 891-7711
- Diane I Lee, MSW(818) 891-7711
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Greater Los Angeles Healthcare System, Sepulveda, CA | Sepulveda | California | 91343 | Cathy A Alessi, MD MPH (SUB_INVESTIGATOR) Jennifer L Martin, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sepulveda, CA
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)PHASE2 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Intracranial Neurophysiological Signatures of Fear and Anxiety in HumansRecruiting · Duke University · Los Angeles, California